- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 22, 2023
Discovery & Translation
Improved CAR immune cell function; plus AlphaMissense and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 9, 2023
Discovery & Translation
Two metabolites that inhibit Th17 differentiation for MS; plus Cirius’ MPC inhibitor for COVID-19 and more
BioCentury’s roundup of translational news
BioCentury | Aug 27, 2021
Distillery Therapeutics
Enhancing CAR T cells activity in solid tumors via BATF expression
BioCentury | Nov 15, 2018
Product R&D
Tempest takes PPAR alpha into cancer
Why Tempest thinks PPARα could succeed in cancer where IDO failed
Items per page:
1 - 4 of 4